SCHEMBL4967948

SCHEMBL4967948

CC(C)(C#N)c1ccccc1C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 4/20 0.42
MAPT P10636 3/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
METAP2 P50579 1/20 0.40
BCAT2 O15382 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
IRAK4 Q9NWZ3 1/20 0.39
PARP1 P09874 5/20 0.38
KMT2A Q03164 1/20 0.36
GAA P10253 2/20 0.36
CTNNB1 P35222 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
ATM Q13315 1/20 0.36
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4987570 0.84 ALDH1A1 (0.46) ALDH1A1KDM4EMAPTHPGDTSHR
SCHEMBL4941832 0.84 KDM4E (0.44) ALDH1A1KDM4EMAPTHPGDTSHR
SCHEMBL5534100 0.79 TSHR (0.49) ALDH1A1KDM4EMAPTTSHRHSD17B10
SCHEMBL1002129 0.79 ALDH1A1 (0.50) ALDH1A1KDM4EMAPTHPGDTSHR
Potassium SCHEMBL30882886 0.77 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTHPGDTSHR
Hydrochloric Acid SCHEMBL20576674 0.77 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTHPGDTSHR
SCHEMBL28004742 0.77 KDM4E (0.48) ALDH1A1KDM4EMAPTHPGDTSHR
SCHEMBL8802426 0.77 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTHPGDTSHR
Bromide SCHEMBL6851251 0.77 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTHPGDTSHR
SCHEMBL28494576 0.77 HSP90AA1 (0.39) TSHRHSP90AA1HSP90AB1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071543-B Pyridine derivatives inhibiting RAF kinase and vascular endothelial growth factor receptor, process for their preparation, pharmaceutical compositions containing them and their use 三进制药株式会社 2021-07-16 CN disclosed
EP-2576566-A1 THIENO (2, 3B) PYRAZINE COMPOUNDS AS B - RAF INHIBITORS MSD Oss B.V. (NL) 2013-04-10 EP disclosed
EP-1966159-A2 CHEMICAL COMPOUNDS AstraZeneca AB (SE) 2008-09-10 EP disclosed
WO-2007071963-A2 QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2007-06-28 WO disclosed